Stay updated on Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision metadata updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page now shows Revision: v3.4.2 instead of Revision: v3.4.1, indicating a minor version update to the site template.SummaryDifference0.0%

- Check59 days agoChange DetectedMinor update: the site revision label changed from v3.4.0 to v3.4.1, a non-significant change that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page revision label has been updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check103 days agoChange DetectedLocations section reorganized into a single 'Locations' list covering California, Illinois, Kansas, North Carolina, Ohio, Tennessee, and Texas, with the separate state location sections removed and the HHS Vulnerability Disclosure removed; revision updated to v3.3.3.SummaryDifference0.7%

Stay in the know with updates to Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial page.